Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study

The Lancet
Jun 20, 2020 Volume 395 Number 10241 p1883-1948, e107-e111
https://www.thelancet.com/journals/lancet/issue/current

 

Articles
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M Kuderer, on behalf of the COVID-19 and Cancer Consortium
Interpretation
Among patients with cancer and COVID-19, 30-day all-cause mortality was high and associated with general risk factors and risk factors unique to patients with cancer. Longer follow-up is needed to better understand the effect of COVID-19 on outcomes in patients with cancer, including the ability to continue specific cancer treatments.